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Background: Two successive laboratory experiments (A and B) were conducted to confirm the efficacy of a new
fipronil and permethrin combination to repel and kill Phlebotomus perniciosus sandflies when applied once topically
on dogs.
Methods: Due to the difficulty to get enough available dogs and sandflies in one run, the study was divided into 2
experiments which had exactly the same design, and were conducted at the same place, with the same
technicians. They compared dogs treated with a combination containing 67.6 mg/mL fipronil + 504.8 mg/mL
permethrin (Frontect®/Frontline Tri-Act®, Merial) to untreated dogs. The treatments were applied topically once
on Day 0. Sandfly exposures were performed on Days 1, 7, 14, 21 and 29 with 80 P. perniciosus female sandflies.
After 60 min, sandflies were assessed for vitality and engorgement status. Live sandflies were kept in an insectary
and observed for mortality counts 4 h after the exposure period ended.
Results: Percent sandfly repellency on treated dogs was 98.2, 98.5, 99.2, 90.9 and 90.3%, for Days 1, 7, 14, 21, and
29, respectively. There was a significant difference (p ≤ 0.05) between the treated and control groups in both
experiments and for the pooled data on every assessment day.
Insecticidal efficacy on treated dogs at 4 h post-exposure on Days 1, 7, 14, 21 and 29 was 98.7, 99.7, 96.8, 93.4,
and 78.9%, respectively. There was a significant difference between the treated and control groups for live
sandflies observed at 4 h post-exposure for all assessment days (p < 0.05).
Conclusions: A single topical administration of a new combination of fipronil and permethrin demonstrated a
significant repellent effect (i.e., > 80%) against P. perniciosus which lasted for 29 days after application. The
repellent effect was accompanied by a significant insecticidal effect on sandflies. The results suggest that in
endemic areas, the application of the fipronil-permethrin combination could be integrated into canine
leishmaniosis prevention program.
Keywords: Repellent, Phlebotomus perniciosus, Sandflies, Fipronil, Permethrin* Correspondence: frederic.beugnet@merial.com
1Merial S.A.S., 29 Av Tony Garnier, 69007 Lyon, France
Full list of author information is available at the end of the article
© 2015 Dumont et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Dumont et al. Parasites & Vectors  (2015) 8:49 Page 2 of 6Abrégé
Contexte: Deux études expérimentales successives (A et B) ont été conduites afin de confirmer l’efficacité d’une
nouvelle combinaison de fipronil et de perméthrine pour repousser et tuer les phlébotomes Phlebotomus
perniciosus après une application unique chez le chien.
Méthodes: En raison de la difficulté à disposer de suffisamment de chiens et de phlébotomes en une fois, l’étude a
été divisée en deux expérimentations ayant le même protocole, conduites au même endroit, et par les mêmes
opérateurs. Elles ont comparées des chiens traités avec une combinaison contenant du fipronil à 67,6 mg/mL + de
la perméthrine à 504,8 mg/mL (Frontect®/Frontline Tri-Act®, Merial) à des chiens non traités. Les traitements ont été
appliqués en topique une fois au jour 0. Les expositions ont été réalisées aux jours 1, 7, 14, 21 et 29, avec 80
phlébotomes P. perniciosus femelles. Après 60 min, les phlébotomes ont été évalués pour leur vitalité et leur statut
de gorgement. Les phlébotomes vivants ont été placés en insectarium et leur mortalité observée/comptabilisée 4 h
après la fin de la période d’exposition.
Résultats: Le pourcentage d’activité répulsive observé chez les chiens traités vis-à-vis des phlébotomes a été de
98,2, 98,5 99,2 90,9 et 90,3%, aux jours 1, 7, 14, 21 et 29, respectivement. A chaque jour d’évaluation, la différence
était significative (p ≤0,05) entre les chiens traités et non traités, dans les deux expérimentations comme pour les
données combinées.
Chez les chiens traités, l’efficacité insecticide 4 h post-exposition était de 98,7, 99,7, 96,8, 93,4, et 78,9% aux jours 1,
7, 14, 21 et 29. A chaque jour d’évaluation, la différence a été significative (p <0,05) entre les groupes traité et non
traité quant au nombre de phlébotomes vivants 4 h post-exposition.
Conclusions: Une seule administration topique de la nouvelle combinaison de fipronil et de perméthrine a
démontré un effet répulsif significatif (i.e., > 80%) contre P. perniciosus durant 29 jours après l’application. L’effet
répulsif était accompagné d’une action insecticide significative sur les phlébotomes. Les résultats suggèrent qu’en
zone d’enzootie, l’application de la combinaison fipronil-perméthrine pourrait être intégrée dans un programme de
prévention de la leishmaniose canine.Background
Leishmaniosis is a serious parasitic disease caused by
flagellated protozoa of the genus Leishmania. The
protozoa are transmitted to animals and humans by
haematophagous female sandflies of the genus Phlebo-
tomus in the Old World and Lutzomyia in the New
World. Although certain wild mammals may be in-
volved in the transmission of leishmaniosis, domestic
dogs appear to be the principal reservoir of Leishmania
infantum throughout the world [1]. In Europe, there is
a tendency for leishmaniosis but also other canine
vector-borne diseases to have an increased distribution
[2]. This is related to several factors, including climate
and social changes [3].
The prevention of canine leishmaniosis in dogs is
based on several measures, including anti-Leishmania
vaccines and methods for protecting healthy dogs
against sandfly bites [4,5]. The studies reported here
were conducted to assess the repellent and insecticidal
efficacies of a new spot on topical combination of
fipronil and permethrin (Frontect®/Frontline Tri-Act®,
Merial) against the main vector of canine leishmaniosis
in Europe (Phlebotomus perniciosus). Such a combin-
ation is intended to provide both repellent and
insecticidal-acaricidal effects against several ectopara-
sites of dogs [6,7].Methods
Two successive experiments were conducted at the
Ecole Nationale Vétérinaire de Toulouse. The 2 exper-
iments were necessary due to the difficulty to include
many dogs and to produce enough sandfly. Experiment A
was also considered as a preliminary exploratory study
whereas Experiment B was conducted according to
Good Clinical Practices (GCP) as described in the
International Cooperation on Harmonisation of Technical
Requirements for Registration of Veterinary Medicinal
Products (VICH) guideline 9 [8].
Animals
Adult Beagle dogs were used in the experiements and
had not been exposed to ectoparasiticides having a
monthly efficacy or shorter 3 months prior to treatment,
and were never exposed to long lasting ectoparasiticides
(Experiment A (Exp. A): 6 males and 4 females, 10.7 to
11.4 months of age, weighing 6.9–9.2 kg; Experiment B
(Exp. B): 8 males and 8 females, 14.1 to 14.9 months of
age, weighing 8.1–10.4 kg). The dogs were housed indi-
vidually in stainless steel cages with an exercise area,
under controlled environmental conditions, fed with a
commercial dry dog food ration, with water available ad
libitum. No concurrent medication was given during the
study. They were managed similarly and with due regard
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ance with Merial Animal Care and Use Guidelines and
in compliance with the French regulatory requirements
and ethical committee of Toulouse Veterinary School.
The dogs were acclimated to the study conditions for at
least 11 days prior to treatment and were observed for
general health conditions throughout the study.
Sandfly exposures
Sandfly exposures were performed one week prior to
treatment for allocation purposes, and after treatment on
Days 1, 7, 14, 21 and 29. Prior to each exposure, animals
were anesthetized with intra-muscular injections of 0.02
to 0.03 mg/kg dexmedetomidine (Dextomidor®, Pfizer),
3.8 to 6.8 mg/kg ketamine (Imalgene® 1000, Merial) and
0.46 to 0.65 mg/kg of Diazepam (Valium®, Roche); placed
individually into a sandfly proof exposure cage; and ex-
posed to 80 P. perniciosus unfed female sandflies (strain
originated from Lisbon, Portugal and maintained under
laboratory conditions for 9 years). After approximately
60 min, live sandflies were removed from the exposure
cage, counted and categorized as engorged (fed) or non-
engorged (unfed). Dead sandflies remaining in the expos-
ure cage or on the dog were counted and categorized as
engorged or non-engorged. The dogs were then returned
to their normal housing. Live sandflies recovered from
each exposure (except pre-treatment) were maintained at
appropriate environmental conditions for approximately
4 h after the exposure period ended, and dead phlebo-
tomes were recovered and counted from each container.
Allocation and treatment
To allocate the dogs, blocks were formed, based on de-
scending pre-treatment counts of fed sandflies and 26
dogs were randomly allocated to the two treatment
groups (10 for Exp. A and 16 for Exp. B). Dogs in
Group 1 served as untreated control dogs. Dogs in
Group 2 were treated on Day 0 with the topical com-
bination of permethrin and fipronil. In Exp. A, 5 dogs
were treated at the minimum recommended dose
(0.1 mL/kg based on Day 0 body weight, corresponding
to a dose of 6.73 mg/kg fipronil and 50.16 mg/kg
permethrin) whereas in Exp. B, 8 dogs were treated
at the recommended commercial dose (1.0 mL for
dogs <10.0 kg, and 2.0 mL for dogs >10.0 to 20 kg,
based on Day 0 body weight, delivering a minimum dose
of 6.76 mg/kg fipronil and 50.48 mg/kg permethrin).
The dose was applied by parting the hair and applying
the formulation directly onto the skin on the dorsal mid-
line of the neck. The total volume was divided into two
approximately equal portions. One fraction was applied
between the base of the skull and the shoulder blades
and the other fraction was applied at the front of the




The total number of engorged (alive + dead) sandflies at
the end of each post-treatment exposure period was
transformed to the natural logarithm of (count + 1) for
calculation of geometric means (GM) by treatment group.
Percent repellency was expressed as the percent reduction
in fed sandflies of the treated group compared to the
control group at each post-treatment exposure day:
100 × [(C-T)/C], where C is the GM of the control
group and T is the GM of the treated group.
Percent insecticidal efficacy
All sandflies were collected at 60 min after exposure and
classified as dead or alive. The live sandflies were put in
containers and observed at 4 h post-exposure. The
number of live sandflies after each post-treatment ex-
posure was calculated by subtracting the number of
dead sandflies at 4 h and the number of dead sandflies
observed at the end of the 60 min exposure. The number
of live sandflies was transformed to the natural logarithm
of (count + 1) for calculation of geometric means. Percent
insecticidal efficacy at 4 h post-exposure was calculated as
100 × [(C-T)/C], where C is the mean of live sandflies in
the control group and T is the mean in the treated group.
The treated group was compared to the control group
using Friedman’s rank test with blocks defined as the
allocation blocks. The testing was two-sided and used a
significance level of 5%.
Results
No health abnormalities related to treatment were
observed throughout the studies, including during
hourly observations conducted for 4 h immediately
after treatment.
In Exp. B, Dog 6277 in the control group vomited on
Day 0 and then was normal through Day 7. The dog did
not eat well from Days 8 to 14 and was not considered
to be suitable for anesthesia and subsequent exposure to
sandflies on Day 14. An intussusception was observed at
ultrasonography on Day 15 and the dog was removed
from the study, therefore the control group of Exp. B
moved from 8 to 7 dogs on Days 14, 21 and 29.
Untreated control dogs had high numbers of engorged
sandflies at the end of the exposure period at all time-
points with means between 54.6 and 68.2 out of 80
(Table 1). With at least 68% of feeding behaviour on
control dogs, it showed a robust sandfly strain population.
The survival rate was also very good with at least 73.1%
sandflies surviving until 4 h after the end of the exposure
times in the control group (Table 2).
Table 1 Percent repellency of Phlebotomus perniciosus in dogs treated with the combination of fipronil and permethrin
(Experiments A & B) based on geometric means
Number of engorged sandflies
Exposure day experiment (A/B) Dogs (n) Untreated dogs Dogs (n) Treated dogs Repellency (%)
1 (A) 5 60.0 5 3.4 94.4* 98.2%*
1 (B) 8 64.4 8 0.4 99.4*
7 (A) 5 60.5 5 3.2 94.7* 98.5%*
7 (B) 8 61.3 8 0.2 99.7*
14 (A) 5 59.3 5 0.4 99.3* 99.2%*
14 (B) 7 63.1 8 0.6 99.1*
21 (A) 5 54.8 5 7.3 86.6* 90.9%*
21 (B) 7 64.7 8 4.6 92.9*
29 (A) 5 54.6 5 1.5 97.3* 90.3%*
29 (B) 7 68.2 8 12.6 81.5*
*Significant difference between the population means of the treated and control groups (p < 0.05).
Right column gives the % repellency based on geometric means obtained for each dog, pooling the two experiments, it is not the simple mean of the two % of
repellency calculated for each experiment.
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Treated dogs had significantly fewer fed sandflies at the
end of the exposure period than untreated control dogs
for all study days (Exp. A, p = 0.025, Exp. B, p ≤ 0.008).
The percent sandfly repellency after 60 min exposure
was 98.2, 98.5, 99.2, 90.9 and 90.3% (Table 1), for Days
1, 7, 14, 21, and 29, respectively.
Insecticidal efficacy
Treated dogs had significantly more dead sandflies at
4 h post-exposure than untreated control dogs for all
challenge days (Exp. A, p = 0.025, Exp. B, p ≤ 0.008).
Percent insecticidal efficacy of the treated group at 4 h
compared to the control group on Days 1, 7, 14, 21 and
29 was 98.7, 99.7, 96.8, 93.4, and 78.9% (Table 2),Table 2 Percent insecticidal efficacy against Phlebotomus pern
combination of fipronil and permethrin (Experiments A & B)
Number of live sandflies
Exposure day experiment (A/B) Dogs (n) Untreated dog
1 (A) 5 74.3
1 (B) 8 73.5
7 (A) 5 75.2
7 (B) 8 72.1
14 (A) 5 74.5
14 (B) 7 72.1
21 (A) 5 75.2
21 (B) 7 74.0
29 (A) 5 74.2
29 (B) 7 75.1
*Significant difference between the population means of the treated and control gr
Right column gives the % insecticidal activity based on geometric means obtained
two % of insecticidal activity calculated for each experiment.respectively. In Exp. A, the insecticidal efficacy was
54.9% on Day 21 and got back to 90.6% on Day 29.
Discussion
The number of female sandflies used for each exposure
was limited to 80 instead of a more classical number of
100 females [8,9] because of the large number of dogs in
each study (10 dogs in Exp. A and 16 dogs in Exp. B)
and the difficulty of rearing large numbers of female
sandflies under laboratory conditions. There was no im-
pact on the outcome of the studies due to the high rates
of feeding and viability in the control groups.
The feeding behaviour of the sandflies on control dogs
showed a robust population on all exposures days with
at least 68% having fed after 60 min in the control group.iciosus observed at 4 h in dogs treated with the
based on Geometric means
s Dogs (n) Treated dogs Efficacy (%)
5 0.3 99.6* 98.7%*
8 1.6 97.9*
5 0 100* 99.7%*
8 0.4 99.5*
5 5.7 92.3* 96.8%*
8 1.2 98.4*
5 33.9 54.9* 93.4%*
8 1.0 98.7*
5 7.0 90.6* 78.9%*
8 25.7 65.7*
oups (p < 0.05).
for each dog, pooling the two experiments, it is not the simple mean of the
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surviving until 4 h after the end of the exposure times in
the control group.
The potential for a topical product to provide protec-
tion against sandfly-transmitted diseases depends on its
ability to prevent the sandflies from taking a blood meal.
Hence, the prevention of sandfly feeding was the major
focus of this study. The new combination product showed
a high repellency rate over one month with a plateau last-
ing until 21 days post-treatment (≥99.2%) and a progres-
sive decrease to 90.3% on Day 29. A repellency over 80%
is considered as a minimum threshold by the registration
agencies and other authors [8,9]. This level of efficacy was
also observed in other similar studies testing topical com-
binations including permethrin. Miro et al. [10] evaluated
the activity of imidacloprid + permethrin (Advantix®)
against P. perniciosus and reported ≥96.45% until Day 14,
92.73% on Day 21 and 74.7% on Day 28. Lienard et al.
[11] assessed the repellent efficacy of another topical
combination of dinotefuran + permethrin + pyriproxyfen
(Vectra 3D), under the same experimental conditions,
in the same location, and with the same Phlebotomus
strain as in the present investigation. The repellency
was 96.9, 99.7, 98.7, 83.5 and 87.0% on days 1, 7, 14, 21
and 28, respectively. The mortality effect was 97.8, 99.8,
73.7, 27.5 and 39.6% on days 1, 7, 14, 21 and 28, respect-
ively. Against P. papatasi, Mencke et al. [12] found
Advantix® efficacy to be ≥93.3% until Day 8, then 80.0,
72.8 and 55.9% on Days 15, 22 and 29, respectively.
Molina et al. [13] tested a topical combination of perme-
thrin alone (Exspot®) against P. perniciosus and reported
efficacy ≥93.4% until Day 8 then 86.8, 67.6 and 61.0% on
Days 15, 22 and 29, respectively. The observed results for
the new topical combination of fipronil and permethrin
are clearly close to what has been already published with
other spot on formulation containing permethrin.
Insecticidal efficacy, as a secondary parameter, was
high until Day 21 (93.4%), decreasing to 78.9% on Day
29. The insecticidal effect can be attributed to the action
of both fipronil and permethrin, whereas the repellent
activity of the product is likely due to the permethrin.
Even if not a direct comparison, the mortality effect
looks higher with the fipronil-permethrin combination
than with the dinotefuran-permethrin-pyriproxyfen [7,11],
under the same experimental conditions in the same la-
boratory and with the same sandfly strain.
In Exp. A, the insecticidal activity dropped on Day 21
to 54.9% and was 90.6% on Day 29, whereas it was
98.7% on Day 21 in Exp. B and then 65.7% on Day 29.
The regular decrease was as expected in Exp. B. The
lower insecticidal activity observed in treated dogs in
Exp. A on Day 21 is difficult to explain as no particular
variation was observed for the repellent effect, and no
variation in the controls. It shows how it is important toinclude enough dogs in a study: 5 dogs is too limited
and the 8 dogs included in Exp. B were important to
compensate these observations. We could argue that the
number of dogs is probably not sufficient and that a
repetition of studies, using the same design, could con-
firm observations. This is certainly why the registration
agencies request at least 2 efficacy studies (called dose
confirmations) to confirm an indication [8,9].
Conclusions
The new combination of fipronil and permethrin demon-
strated a significant repellent effect against P. perniciosus
bites as soon as it was applied on the dogs, and its
repellent efficacy lasted 4 weeks. The results suggest that
in endemic areas, the regular application of the new com-
bination could be integrated in a canine leishmaniosis pre-
vention program.
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